Globe Life (NYSE:GL) Shares Gap Down Following Weak Earnings

Shares of Globe Life Inc. (NYSE:GL) gapped down prior to trading on Thursday following a weaker than expected earnings announcement. The stock had previously closed at $184.00, but opened at $170.18. Globe Life shares last traded at $172.19, with a volume of 216,922 shares traded.

The company reported $3.61 EPS for the quarter, missing the consensus estimate of $3.67 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.59 billion. Globe Life had a return on equity of 20.73% and a net margin of 19.58%.Globe Life’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter last year, the business earned $3.05 EPS. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS.

Globe Life Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Monday, July 6th will be issued a dividend of $0.33 per share. The ex-dividend date of this dividend is Monday, July 6th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is presently 9.13%.

Key Stories Impacting Globe Life

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life raised its FY 2026 EPS guidance to $15.55-$15.95, signaling management confidence in the business outlook. Globe Life Inc. Reports Second Quarter 2026 Results
• Positive Sentiment: Quarterly revenue rose 8% year over year to $1.60 billion, slightly ahead of estimates, helped by broad underwriting gains and stronger investment income. Insurer Globe Life’s second-quarter profit rises on strong underwriting income
• Positive Sentiment: TD Cowen raised its price target on Globe Life to $225 and kept a buy rating, reflecting a constructive view on the stock’s longer-term potential. Benzinga
• Neutral Sentiment: Net operating income was $3.61 per share, improving from $3.27 a year ago but just below the consensus estimate of $3.67. Globe Life Inc. Reports Second Quarter 2026 Results
• Negative Sentiment: Operating expenses escalated enough to pressure the quarter and contribute to the earnings miss, which may be the main reason investors are selling the stock today. Globe Life Q2 Earnings Miss Estimates on Escalating Expenses

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Keefe, Bruyette & Woods upped their target price on shares of Globe Life from $180.00 to $192.00 and gave the stock an “outperform” rating in a report on Monday, July 13th. Jefferies Financial Group lifted their price target on shares of Globe Life from $147.00 to $166.00 and gave the company a “hold” rating in a report on Friday, July 10th. Morgan Stanley boosted their price target on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. JPMorgan Chase & Co. upped their price objective on shares of Globe Life from $181.00 to $201.00 and gave the stock an “overweight” rating in a research note on Tuesday. Finally, Truist Financial upped their price objective on shares of Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Friday, April 24th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $187.60.

Insiders Place Their Bets

In related news, CEO Frank M. Svoboda sold 10,000 shares of the company’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $166.68, for a total transaction of $1,666,800.00. Following the transaction, the chief executive officer owned 54,020 shares in the company, valued at $9,004,053.60. This represents a 15.62% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Cheryl Alston sold 8,258 shares of the stock in a transaction dated Thursday, June 25th. The stock was sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the sale, the director directly owned 16,621 shares in the company, valued at approximately $2,979,148.04. This represents a 33.19% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 90,187 shares of company stock valued at $14,299,874. 2.11% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Globe Life

Large investors have recently modified their holdings of the stock. CYBER HORNET ETFs LLC acquired a new stake in shares of Globe Life in the second quarter valued at approximately $28,000. Hilton Head Capital Partners LLC acquired a new position in Globe Life during the 4th quarter worth $30,000. MUFG Securities EMEA plc acquired a new position in Globe Life during the 2nd quarter worth $31,000. Torren Management LLC acquired a new position in Globe Life during the 4th quarter worth $37,000. Finally, AdvisorNet Financial Inc boosted its position in Globe Life by 41.1% in the 1st quarter. AdvisorNet Financial Inc now owns 316 shares of the company’s stock valued at $44,000 after buying an additional 92 shares during the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Price Performance

The stock has a 50-day simple moving average of $168.70 and a 200 day simple moving average of $152.76. The stock has a market capitalization of $13.25 billion, a P/E ratio of 11.33 and a beta of 0.47. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.